National Comprehensive Cancer Network

About NCCN

Thomas A. D’Amico, MD Elected Chairman of NCCN Board of Directors

Thomas A. D’Amico, MD, of the Duke Comprehensive Cancer Center, is the new chairman of the NCCN Board of Directors succeeding Al B. Benson III, MD, of Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

April 1, 2010

FORT WASHINGTON, PA — Thomas A. D’Amico, MD, of the Duke Comprehensive Cancer Center has been elected to the position of chairman of the National Comprehensive Cancer Network® (NCCN®) Board of Directors. Dr. D’Amico was previously vice-chairman of the board and succeeds Al B. Benson III, MD. The change in leadership was formalized at a recent NCCN Board of Directors meeting held in conjunction with the NCCN 15th Annual Conference.

I thank Dr. Benson for his vision, leadership and inspiration. He`s been an outstanding chairman of the board, said William T. McGivney, PhD, chief executive officer of NCCN. I`m confident Dr. D’Amico will be an excellent successor. He`s been a devoted, enthusiastic friend of NCCN for many years and I look forward to working with him in his new leadership role.

Dr. D’Amico is director of clinical oncology, program director of thoracic surgery, and professor in the department of surgery at Duke Comprehensive Cancer Center. He is a recognized leader in the field of oncology with interests including lung cancer, esophageal cancer, and thoracic surgery. Dr. D’Amico remains active in the research community with a focus on the molecular biology of lung cancer and esophageal cancer and the genomic analysis of mutations. He is a member of several NCCN committees and serves on the NCCN Guidelines™ Panels for Esophageal/Gastric Cancers and for Non-Small Cell Lung Cancer.

“I am honored to be chosen for this prestigious position,” said Dr. D’Amico. “Given the wealth of ideas and spirit of the members who comprise the board, there is no doubt in my mind that we can continue to make an outstanding organization such as NCCN even better.”

Dr. Benson, of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University was chairman of the board since 2007. A committed member of several NCCN committees and NCCN Guidelines Panels, Dr. Benson will remain a member of the board.

Succeeding Dr. D’Amico as vice-chairman of the NCCN Board of Directors is Samuel M. Silver, MD, PhD, of the University of Michigan Comprehensive Cancer Center.

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. For more information, visit

The NCCN Member Institutions are:

  • Fred & Pamela Buffett Cancer Center
  • Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
  • City of Hope Comprehensive Cancer Center
  • Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center
  • Duke Cancer Institute
  • Fox Chase Cancer Center
  • Huntsman Cancer Institute at the University of Utah
  • Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Mayo Clinic Cancer Center
  • Memorial Sloan Kettering Cancer Center
  • Moffitt Cancer Center
  • The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
  • Roswell Park Comprehensive Cancer Center
  • Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
  • St. Jude Children's Research Hospital/The University of Tennessee Health Science Center
  • Stanford Cancer Institute
  • University of Alabama at Birmingham Comprehensive Cancer Center
  • UC San Diego Moores Cancer Center
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • University of Colorado Cancer Center
  • University of Michigan Rogel Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • University of Wisconsin Carbone Cancer Center
  • Vanderbilt-Ingram Cancer Center
  • Yale Cancer Center/Smilow Cancer Hospital